A Double-Blind, Multicenter Efficacy Safety Study of Pregabalin (Lyrica) as a Monotherapy in Patients with partial Seziures

Grants and Contracts Details

StatusFinished
Effective start/end date10/10/0712/31/11

Funding

  • Pfizer Inc.: $95,840.00